ScreenRant on MSN19h
D&Ds Most Iconic Species Are Better Than Ever In The 2024 Players Handbook
The elf and dwarf species options in Dungeons & Dragons receive some much-needed improvements in the newest iteration of the ...
DS 3 E-Tense review: Compact and comfortable electric SUV
A compact crossover that oozes French chic, with an upmarket image and a price to match. Updated in 2023 with a new battery ...
Man Group PLC : Form 8.3 - Smith (DS) plc
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING ...
Fleet News4d
DS 4 PureTech long-term test | Great looks, clunky gearbox
Company car drivers will face a 32% benefit-in-kind (BiK) tax charge for the DS 4 PureTech, owing to its CO2 emissions of ...
GameRant on MSN4d
Pokemon Fan Creates Awesome Artwork of Fairy, Psychic, and Ice-Types
A talented Pokemon fan online has shared three excellent pieces of fan art, depicting various popular Fairy, Psychic, and Ice ...
Daiichi Sankyo posts positive DS-9606 clinical trial results in solid tumours
Daiichi Sankyo has reported positive initial findings from the dose escalation phase of the first-in-human Phase I trial of ...
Business Wire4d
DS-9606 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors
Initial results from dose escalation in the first-in-human phase 1 trial of DS-9606 suggest early promising clinical activity in patients with advance ...
Rigid Packaging Market: CAGR 4.6% Size, Share, And Trend Forecast (2024-2031) Amcor Limited, DS Smith Plc., Holmen AB
Rigid packaging market is to be valued at USD 227.36 Bn in 2024 and is expected to reach USD 311.48 Bn by 2031, exhibiting (CAGR) of 4.6% from 2024 to 2031. Mr. Shah Coherent Market Insights Pvt. Ltd.
Pharmabiz3d
Phase 1 trial of DS-9606 shows promising preliminary clinical activity in patients with advanced solid tumours
Initial results from dose escalation in the first in-human phase 1 trial of DS-9606 suggest early promising clinical activity in patients with advanced solid tumours known to express Claudin-6 (CLDN6) ...
Business Insider7d
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc 13-Sep-2024 / 14:17 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES ...
Incentive AS - Form 8.3 - DS Smith Plc
Owner or controller of interests and short positions disclosed, if different from 1(a): (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Details of any indemnity ...
Form 8.3 - The Vanguard Group, Inc.: DS Smith PLC
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: DS Smith PLC 26-Aug-2024 / 13:49 GMT/BST (b) Owner or controller of interests and short positions disclosed, if different from 1 (a): ...